Gene Therapy Solutions
We provide innovative payer solutions to help finance and manage the risk of new gene therapies
Explore our solutions to help address the growing gene therapy pipeline
Reinsurance
Reinsurance pool product for health plans that covers the cost of gene therapy ingredients to protect against large, catastrophic claims, and offers back-end management services
Gene Therapy Stop Loss
A gene-therapy-only stop loss product designed to protect large, self-insured employers from the frequency and severity of these one-time treatments
Cost Containment Solutions
Access to a variety of partnerships with specialty vendors and service providers that support clinical intervention and cost-saving initiatives to manage exposure to high-cost claims
For more information about innovative gene therapy products, contact your BCS representative.
BCS Financial Leading the Way with New Gene Therapy Reinsurance Solutions
New solutions aim to improve access to growing gene therapy pipeline by financing and mitigating health payer risk CHICAGO, Nov. 28, 2023 /PRNewswire/ — BCS Financial has expanded its stop loss and reinsurance offerings to include new payer solutions in response to the rapidly growing gene therapy pipeline. With more than 20 therapies expected to hit the…
Read More